Oppenheimer downgraded Korro Bio (KRRO) to Perform from Outperform.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Korro failure strengthens Wave Life Sciences position, says Jefferies
- Korro Bio downgraded to Neutral from Overweight at Piper Sandler
- Korro Bio downgraded to Neutral from Buy at H.C. Wainwright
- Korro Bio downgraded to Sector Perform from Outperform at RBC Capital
- Korro Bio downgraded to Market Perform from Outperform at William Blair